Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 282-104-8 | CAS number: 84100-23-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames assay: negative (BASF, 2009)
HPRT: negative (BASF 2015)
MNT in vitro: negative (BASF 2015)
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-10-27 to 2009-11-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- liver S9 mix from induced rats
- Test concentrations with justification for top dose:
- 22 µg - 5600 µg/plate (standard plate test, all tester strains)
1 µg - 250 µg/plate (preincubation test: TA 1535, TA 1537)
2 µg - 500 µg/plate (preincubation test: TA 100, TA 98)
22 µg - 5600 µg/plate (preincubation test: E. coli) - Vehicle / solvent:
- - Vehicle used: DMSO
- Justification for choice of solvent/vehicle: Due to the limited solubility of the test item in water, DMSO was used as vehicle, which had been demonstrated to be suitable in bacterial reverse mutation tests and for which historical control data are available. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 2-AA
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- with S9 mix (TA98, TA100, TA1535, TA1537, WP2 uvr A)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- MNNG
- Positive control substance:
- other: N-methyl-N`-nitro-N-nitrosoguanidine
- Remarks:
- without S9 mix (TA1535, TA100)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- NOPD
- Positive control substance:
- other: 4-nitro-o-phenylenediamine
- Remarks:
- without S9 mix (TA 98)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- AAC
- Positive control substance:
- 9-aminoacridine
- Remarks:
- without S9 mix (TA1537)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 4-NQO
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- without S9 mix (WP2 uvr A)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 -72 hours in the dark
SELECTION AGENT (mutation assays): not used
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: other: reduced background lawn, decrease in number of revertants and reduction in the titer - Evaluation criteria:
- Generally, the experiment is considered valid if the following criteria are met:
- The number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain.
- The sterility controls revealed no indication of bacterial contamination.
- The positive control items both with and without S9 mix induced a distinct increase in the number of revertant colonies within the range of the historical positive control data or above.
- The titer of viable bacteria was ≥ 10^8/mL
The test item is considered positive in this assay if the following criteria are met:
- A dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system.
A test item is generally considered non-mutagenic in this test if:
-The number of revertants for all tester strains were within the historical negative control range under all experimental conditions in at least two experiments carried out independently of each other. - Key result
- Species / strain:
- E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- Raw data is listed under "any other information on results incl. tables"
- Cytotoxicity / choice of top concentrations:
- other: Salmonella strains only depending on the strain and test conditions from about 125 µg/plate onward.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- Raw data is listed under "any other information on results incl. tables"
- Cytotoxicity / choice of top concentrations:
- other: A bacteriotoxic effect was observed with the Salmonella strains only depending on the strain and test conditions from about 125 µg/plate onward.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: Salmonella strains only depending on the strain and test conditions from about 125 µg/plate onward.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: Salmonella strains only depending on the strain and test conditions from about 125 µg/plate onward.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No
- Effects of osmolality: No
- Evaporation from medium: No
- Water solubility: No
- Precipitation: No test item precipitation was found with and without S9 mix.
RANGE-FINDING/SCREENING STUDIES: Not performed
COMPARISON WITH HISTORICAL CONTROL DATA:
The number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain. In addition, the positive control items both with and without S9 mix induced a significant increase in the number of revertant colonies within the range of the historical positive control data or above.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
A bacteriotoxic effect (reduced his- background growth, decrease in the number of his+ revertants, reduction in the titer) was observed in the standard plate test using the Salmonella strains depending on the strain and test conditions from about 250 μg/plate onward. In the preincubation assay bacteriotoxicity (reduced his- background growth, decrease in the number of his+ revertants, reduction in the titer) was observed depending on the strain and test conditions using the Salmonella strains from about 125 μg/plate onward. With the tester strain E. coli WP2uvrA no bacteriotoxicity was observed in all experiments up to the highest required concentration. - Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM (minimal essential medium)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 induced with Phenobarbital/β-naphthoflavone
- Test concentrations with justification for top dose:
- Experiment IA + II: 4.2; 8.4; 16.9; 33.7; 67.4; 134.9; 269.8; 539.5; 1079.0; 2158.0 (with S9 mix/ 4h)
Experiment IB: 0.08; 0.16; 0.3; 0.6; 1.3; 2.5; 5.0; 10.0; 20.0; 4.0 (without S9 mix /4 h)
Experiment II: 0.03; 0.07; 0.13; 0.26; 0.53; 1.05; 2.1; 4.2; 8.4; 16.9 (without S9 mix/24h) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- other: Griseofulvin
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 h or 24 h
- Fixation time (start of exposure up to fixation or harvest of cells): 24 h
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 2000
DETERMINATION OF CYTOTOXICITY
- Method: relative increase in cell counts (RICC) + proliferation index (PI) - Evaluation criteria:
- A test item can be classified as mutagenic if:
− The number of micronucleated cells exceeds both the value of the concurrent negative control and the range of the historical negative control data.
− A significant, dose-related and reproducible increase in the number of cells containing micronuclei is observed - Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- hypoxanthine-guanine phosphoribosyl transferase (HPRT)
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM (minimal essential medium)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver mix S9 (induced with Phenobarbital/β-naphthoflavone)
- Test concentrations with justification for top dose:
- Test 1: 0.27; 0.55; 1.1; 2.2; 4.4 µg/mL (without S9 mix); 35.0; 70.0; 140.0; 210.0; 280.0 µg/mL (with S9 mix)
Test 2: 2.0; 3.0; 4.0; 6.0; 8.0 µg/mL (without S9 mix); 105.0; 140.0; 210.0; 245.0; 280.0 µg/mL (with S9 mix) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 24 h
- Exposure duration: 4 h
- Expression time (cells in growth medium): 7 days
- Selection time (if incubation with a selection agent): 8 days
- Fixation time (start of exposure up to fixation or harvest of cells): 15 days
SELECTION AGENT (mutation assays): 6-thioguanine'; 11 µg/mL
NUMBER OF REPLICATIONS: 2 - Evaluation criteria:
- A test item is classified as mutagenic if it reproducibly induces a mutation frequency that is three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment.
The test item is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed. - Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No substantial and reproducible dose dependent increase of the mutation frequency was observed up to the maximum concentration with and without metabolic activation.
Appropriate reference mutagens (EMS and DMBA), used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
Referenceopen allclose all
Table 1: First standard plate test
Dose (µg/plate) | Mean number of revertant colonies/3 replicate plates with different strains of Salmonella typhimurium and E.coli | ||||
TA1535 | TA1537 | TA98 | TA100 | WP2 uvr A | |
Results with S9 mix | |||||
Solvent control | 18 | 10 | 37 | 128 | 48 |
Positive control | 125 | 177 | 674 | 896 | 227 |
22 |
20 |
10 | 36 | 119 | 48 |
112 |
19 |
9 | 29 | 101 | 41 |
560 | 9 B | 3 B | 15 B | 10 B | 48 |
2800 | 0 B | 0 B | 0 B | 0 B | 39 |
5600 | 0 B | 0 B | 0 B | 0 B | 43 |
Results without S9 mix | |||||
Solvent control | 18 | 11 | 33 | 120 | 42 |
Positive control | 864 | 460 | 738 | 861 | 895 |
22 |
17 |
12 | 31 | 112 | 47 |
112 | 16 | 8 | 23 | 92 | 44 |
560 | 8 B | 3 B | 14 B | 34 B | 43 |
2800 | 0 B | 0 B | 0 B | 0 B | 44 |
5600 | 0 B | 0 B | 0 B | 0 B | 36 |
B= reduced background lawn
Table 2: Second standard plate test with S. typhimurium strains
Dose (µg/plate) | Mean number of revertant colonies/3 replicate plates with different strains of Salmonella typhimurium and E.coli | |||
TA1535 | TA1537 | TA98 | TA100 | |
Results with S9 mix | ||||
Solvent control | 20 | 9 | 32 | 94 |
Positive control | 150 | 174 | 726 | 864 |
31.3 |
21 |
9 | 22 | 90 |
62.5 |
17 |
8 | 27 | 86 |
125 | 18 | 8 | 34 | 89 |
250 | 12 | 7 | 22 | 87 |
500 | 8 B | 3 B | 10 B | 23 B |
Results without S9 mix | ||||
Solvent control | 21 | 8 | 33 | 90 |
Positive control | 992 | 456 | 471 | 945 |
31.3 |
21 |
8 | 32 | 85 |
62.5 |
20 |
7 | 29 | 77 |
125 | 19 | 8 | 31 | 90 |
250 | 11 | 6 | 34 | 78 |
500 | 6 B | 4 B | 13 B | 21 B |
B= reduce background lawn
Table 3 preincubation test with TA1535, TA1537
Dose (µg/plate) | Mean number of revertant colonies/3 replicates | |
TA1535 | TA1537 | |
Results with S9 mix | ||
Solvent control | 18 | 8 |
Positive control | 140 | 134 |
1 |
17 | 5 |
5 |
16 | 7 |
25 | 17 | 7 |
125 | 15 | 6 |
250 | 5 B | 3 B |
Results without S9 mix | ||
Solvent control | 18 | 10 |
Positive control | 573 | 380 |
1 |
19 |
7 |
5 |
19 |
10 |
25 | 16 | 8 |
125 | 11 | 6 |
250 | 7 B | 1 B |
B= reduced background lawn
Table 4 preincubation test with TA98, TA100
Dose (µg/plate) | Mean number of revertant colonies/3 replicates | |
TA100 | TA 98 | |
Results with S9 mix | ||
Solvent control | 93 | 30 |
Positive control | 939 | 566 |
2 |
98 |
25 |
10 |
101 |
29 |
50 | 87 | 25 |
250 | 83 | 27 |
500 | 19 B | 9 B |
Results without S9 mix | ||
Solvent control | 95 | 28 |
Positive control | 1038 | 414 |
2 |
94 |
25 |
10 |
97 |
32 |
50 | 103 | 22 |
250 | 81 | 24 |
500 | 19 B | 14 B |
B = reduced background lawn
Table 5 preincubation test with WP2 uvr A
Dose (µg/plate) | Mean number of revertant colonies/3 replicates | |
WP2 uvr A | ||
Results with S9 mix | ||
Solvent control | 33 |
|
Positive control | 240 |
|
22 |
31 |
|
112 |
34 |
|
560 | 29 |
|
2800 | 34 |
|
5600 | 33 |
|
Results without S9 mix | ||
Solvent control | 48 |
|
Positive control | 872 |
|
22 |
45 |
|
112 |
45 |
|
560 | 47 |
|
2800 | 46 |
|
5600 | 51 |
Summary of results
Exp. |
Preparation interval |
Test item concentration in µg/ml |
Proliferation Index |
RICC in % |
Cytotoxicity in % |
Micronucleated Cells* in % |
Exposure period 4 hrs without S9 mix |
||||||
IB |
24hrs |
Solvent control1 |
2.74 |
100 |
0 |
1.20 |
Positive control2 |
2.42 |
19 |
81 |
7.45S |
||
0.08 |
2.86 |
171 |
0# |
0.90 |
||
0.16 |
2.83 |
89 |
11 |
0.65 |
||
0.3 |
2.86 |
44 |
56 |
0.90 |
||
1.3 |
2.62 |
16 |
84 |
0.85 |
||
2.5 |
2.66 |
-20 |
n.a. |
0.60 |
||
Exposure period 24 hrs without S9 mix |
||||||
II |
24 hrs |
Solvent control1 |
2.88 |
100 |
0 |
0.85 |
|
|
Positive control3 |
2.55 |
63 |
37 |
7.95S |
0.26 |
2.93 |
80 |
20 |
1.20 |
||
0.53 |
2.93 |
54 |
46 |
1.20 |
||
1.05 |
2.92 |
66 |
34 |
1.45 |
||
2.1 |
2.80 |
21 |
79 |
0.95 |
||
* The number of micronucleated cells was determined in a sample of 2000 cells #Not cytotoxic since the RICC is higher than the solvent control value SNumber of micronucleated cells statistically significantly higher than corresponding control values n.a. Not analysable, because the cell number of the solvent control or treated cultures was lower after treatment 1DMSO 0.5 % (v/v) 2Mitomycin C 0.1μg/mL 3Griseofulvin 8.0μg/mL |
||||||
Exposure period 4 hrs with S9 mix |
||||||
IA |
24 hrs |
Solvent control1 |
2.31 |
100 |
0 |
0.60 |
|
|
Positive control2 |
1.64 |
0 |
100 |
17.20S |
16.9 |
2.40 |
64 |
36 |
1.15 |
||
33.7 |
2.26 |
32 |
38 |
0.60 |
||
67.4 |
2.34 |
54 |
46 |
0.65 |
||
134.9 |
2.20 |
29 |
71 |
0.65 |
||
269.8 |
2.13 |
-52 |
n.a. |
|
||
II |
24 hrs |
Solvent control1 |
2.84 |
100 |
0 |
1.20 |
|
|
Positive control2 |
1.64 |
-15 |
n.a. |
12.45S |
33.7 |
2.78 |
61 |
39 |
0.90 |
||
67.4** |
2.74 |
84 |
16 |
1.45 |
||
134.9** |
2.63 |
75 |
25 |
1.58 |
||
269.8** |
2.38 |
34 |
66 |
1.43 |
* The number of micronucleated cells was determined in a sample of 2000 cells
** The number of micronucleated cells was determined in a sample of 4000 cells
SNumber of micronucleated cells statistically significantly higher than corresponding control values
n.a. Not analysable, because the cell number of the solvent control or treated cultures was lower after treatment
1DMSO 0.5 % (v/v)
2CPA 10.0μg/mL
3CPA 15.0 μg/mL
In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, Laromer TBCH is considered to be non-mutagenic in this HPRT assay.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Ames
In a reverse gene mutation assay in bacteria according to OECD 471 and EU method B. 13 (BASF, 2009), strains of S. typhimurium (TA98, TA100, TA1535, TA1537) and E. coli (WP2 uvr A) were exposed to the test substance in DMSO at concentration ranges listed down below. A standard plate test (SPT) and a preincubation test (PIT) both with and without metabolic activation were performed.
22 - 5600 μg/plate (SPT, all test strains)
1 - 250 μg/plate (PIT: TA 1535, TA 1537)
2 - 500 μg/plate (PIT: TA 100, TA 98)
22 - 5600 μg/plate (PIT: E. coli)
Three independent experiments were performed, two standard plate tests and one preincubation test. No precipitation of the test item was found with and without S9 mix. A bacteriotoxic effect was observed only with the Salmonella strains in both the standard plate and the preincubation test from about 125 µL/plate onwards. A relevant increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the preincubation test either without S9 mix or after the addition of a metabolizing system. Thus, under the experimental conditions of this study, the test substance is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
HPRT
In a study according to OECD 476, two independent experiments each with and without metabolic activation were performed to assess the potential of Laromer TBCH to induce gene mutations in mammalian cells (BASF 2015). Exposure time was 4h in all experiments. The test substance was applied up to 280 µg/mL in the presence of S9 and up to 8µg/ml without the addition of S9. Concentrations were limited by cytotoxic effects. No substantial and reproducible dose dependent increase of the mutation frequency was observed up to the maximum concentration with and without metabolic activation. Appropriate reference mutagens (EMS and DMBA), used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system. In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells.
MNT in vitro
In a study according to OECD 487, Chinese hamster V79 cells were exposed to Laromer TBCH and evaluated for the induction of micronuclei (BASF 2015). The maximum concentrations used were limited by the cytotoxicity of the test item. In the absence of a metabolic activation system, up to 2.5 µg/mL or 2.1 µg/mL could be used, if the cells were treated for 4h or 24h, respectively. In the presence of S9 mix, the cells were treated for 4h with up to 269.8 µg/mL. In each experimental group two parallel cultures were analysed. Per culture at least 1000 cells were evaluated for cytogenetic damage. Neither a statistically significant nor a biologically relevant increase in the number of micronucleated cells was observed after treatment with the test item. Appropriate mutagens (MMC, Griseofulvin and CPA) were used as positive controls. They induced statistically significant increases in the number of cells with micronuclei.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The registered substance did not cause gene mutations in bacteria or mammalian cells, nor chromosomal damage. Consequently, there is no need for classification for mutagenicity under Regulation (EC) No 1272/2008, as amended for the eighteenth time in Regulation (EU) 2022/692.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.